The healthspan-focused fund that led Ilant Health's $15 million Series A. Its partner's public forecast of a billion-dollar outcome is an investor's confidence, not a clinical result.
The healthspan-focused fund that led Ilant Health's $15 million Series A. Its partner's public forecast of a billion-dollar outcome is an investor's confidence, not a clinical result.